Souhaitez-vous accéder aux communiqués récents ?

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SIM0505 for the treatment of women with platinum resistant ovarian cancer (PROC) Phase 1 data for SIM0505 to be...

BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the company will present new...

ZUG, Switzerland and BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual Needham...

ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight...

FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to support potential accelerated approval in second-line HNSCC and cervical cancer Updated CRB-701...

Liquidia to participate in Raymond James Biotech Innovation Symposium and 25th Annual Needham Virtual Healthcare Conference in April 2026.

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

SAN FRANCISCO, April 07, 2026 (GLOBE NEWSWIRE) -- Everbright Health, an AI-enabled services platform that helps mental health providers deliver advanced interventions as part of everyday care,...

National education campaign aims to educate Americans about antibodies and their role in immune healthCampaign centerpiece, AntibodiesforAnyBody.com, offers an interactive immune health wellness...

Greeley, Colorado, April 07, 2026 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a cannabinoid manufacturer focused on pharmaceutical-grade production, announces active...